Catheters and Active Implantable CDMO Market Size, Share & Trends Analysis Distribution by Service Category (Catheters (Cardiac Catheters, Urology Catheters, Neurovascular Catheters) Active Implantable Devices (Neuromodulation Devices, Structural Heart Devices, Heart Failure Devices, Urology Implantable Devices), Endoscopy Devices), End User- and Segment Forecasts, 2024-2031

The Catheters and Active Implantable CDMO Market Size is valued at USD 7.01 Bn in 2023 and is predicted to reach USD 14.12 Bn by the year 2031 at an 9.4% CAGR during the forecast period for 2024-2031.

Catheters and Active Implantable CDMO is a significant market in the health care business, which develops and manufactures critical medical devices. A catheter is a flexible tube that assists in the drainage of fluids or administration of medication, with monitoring for various bodily functions, thus greatly contributing to the cure of diseases such as cardiovascular diseases and diabetes. Active implantable devices are placed in various parts of the body and must be powered by an external source, including cardiac pacemakers, defibrillators, and neurostimulators. Such devices monitor physiological parameters and deliver targeted therapies aimed at improving the patient's outcomes as well as quality of life.

Contract Development and Manufacturing Organizations (CDMOs) that specialize in catheters and AIDs supply critical design, development, and large-volume manufacturing of these products. Such CDMOs play an extremely critical role in meeting all the requirements of regulations while maintaining innovation as well as cost-effectiveness. The increasing numbers of medical device companies involved in outsourcing their manufacturing represent a major growth factor, as this move allows them to focus more on core competencies. Demand is increasing for advanced catheter technologies and AIDs propelled by an aging population worldwide and shifting needs in healthcare that are likely to fuel market growth soon.

Competitive Landscape

Some of the Key Players in Catheters and Active Implantable CDMO Market:

• Integer Holdings Corporation (US)
• Cirtec (US)
• Biomerics (US)
• Switchback Medical (US)
• Velentium LLC (US)
• Heraeus Group (Germany)
• Zeus Company LLC (US)
• Veranex (US)
• Freudenberg Medical (US)
• Medeologix (Taiwan)

Market Segmentation:

The catheters and active implantable CDMO market is segmented by service category, end user. By service category the market is segmented into catheters, active implantable devices, endoscopy devices, others. Catheters is sub segmented into cardiac catheters, urology catheters, neurovascular catheters, others. Active implantable devices is sub segmented into neuromodulation devices, structural heart devices, heart failure devices, urology implantable devices, others. Neuromodulation devices is sub segmented into spinal cord stimulators, deep brain stimulators, others. Structural heart devices is sub segmented into valve implants, stents and shunts, others.  Heart failure devices percutaneous left ventricular assist device (LVAD), percutaneous right ventricular support devices (RVAD), others. By end user the market is categorized into medical device OEM companies, academic and research institutes, government agencies.

Active Implantable Devices Segment is Expected to Drive the Catheters and Active Implantable CDMO Market

The Catheters and Active Implantable CDMO Market is primarily driven by the active implantable devices segment, experiencing robust growth due to several factors. Growing prevalence rates of chronic diseases, including cardiovascular and neurological conditions like heart failure, arrhythmias, and epilepsy, are rising the demand for products including the implantable cardioverter-defibrillator and neurostimulator. The efficiency of these devices, communication through wireless means, and biocompatibility of the materials used are making them more and more effective and user-friendly. Remote monitoring of patients is one such feature that has contributed positively to the outcome. Another driver is the aging population, who are more prone to chronic conditions that would continue to be there for a long time, thereby boosting demand for active implantable devices, as healthcare systems start to grapple with this demographic change.

Medical Device OEM Companies is Growing at the Highest Rate in the Catheters and Active Implantable CDMO Market.

The primary growth driver for the market for catheters and active implantable CDMO is medical device OEM companies, which is one of the largest segment categories. These companies have always been pioneers for innovative development in medical technology, with specific focus areas being catheters and active implantable products. These areas alone create such mass demand for new products that growth has been primarily led by this type of company. Further, outsourcing of manufacturing operations to CDMOs allows OEMs to concentrate better on core competencies such as research and development with the added advantage of being able to capitalize on CDMO capabilities, thus increasing efficiency and shortening time-to-market. Complexity in regulatory compliance in medical devices also compels OEMs to work with a CDMO to assure their products meet very strict quality and safety standards.

Regionally, Asia-Pacific Led the Catheters and Active Implantable CDMO Market.

Active implantable CDMO market in catheters primarily is led by the North America region which has been driven by some key factors. More advanced catheter and implantable device technology developed by the leading medical device companies augments the portfolio of the patient's outcomes for better recovery. Innovation with safety and efficacy also assists this region. Better healthcare infrastructure, more developed hospitals, and research centers are the main emerging grounds in North America for adopting new technologies. Growing healthcare needs primarily due to an older population and a high prevalence of chronic diseases, such as cardiovascular diseases, boost the demand for catheters and active implantable devices in the region.

Catheters and Active Implantable CDMO Market Report Scope